{"DataElement":{"publicId":"2438155","version":"1","preferredName":"Pharmacologic Substance Cancer Molecular Analysis Project Pharmacologic Substance Flag java.lang.Boolean","preferredDefinition":"A natural, synthetic or semi-synthetic substance including endogenous body substance used to diagnose, prevent, maintain, treat or analyze abnormal and normal biological functions in vivo or in vitro._Through the Cancer Molecular Analysis Project (CMAP), NCI facilitates the identification and evaluation of molecular targets by integrating comprehensive molecular characterizations of cancer and making the data and infrastructure publicly accessible. CMAP permits investigators to 1) Discover molecular targets, 2) Assess their validity and interaction with other targets, 3) Determine if there are therapeutic agents that can act on specific targets, 4) Screen for possible toxicity, and 5) Determine whether there are clinical trials evaluating these agents. (http://plan2005.cancer.gov/bioinformatics.html):A natural, synthetic or semi-synthetic substance including endogenous body substance used to diagnose, prevent, maintain, treat or analyze abnormal and normal biological functions in vivo or in vitro.:An indicator that can be set or unset in order to signal whether a particular condition is true. The indicator usually takes the form of a single binary digit, or bit (either 0 or 1). (from Dictionary of Computers)_Value Domain for java language Boolean datatype","longName":"2437951v1.0:2178538v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2437951","version":"1","preferredName":"Pharmacologic Substance Cancer Molecular Analysis Project Pharmacologic Substance Flag","preferredDefinition":"A natural, synthetic or semi-synthetic substance including endogenous body substance used to diagnose, prevent, maintain, treat or analyze abnormal and normal biological functions in vivo or in vitro._Through the Cancer Molecular Analysis Project (CMAP), NCI facilitates the identification and evaluation of molecular targets by integrating comprehensive molecular characterizations of cancer and making the data and infrastructure publicly accessible. CMAP permits investigators to 1) Discover molecular targets, 2) Assess their validity and interaction with other targets, 3) Determine if there are therapeutic agents that can act on specific targets, 4) Screen for possible toxicity, and 5) Determine whether there are clinical trials evaluating these agents. (http://plan2005.cancer.gov/bioinformatics.html):A natural, synthetic or semi-synthetic substance including endogenous body substance used to diagnose, prevent, maintain, treat or analyze abnormal and normal biological functions in vivo or in vitro.:An indicator that can be set or unset in order to signal whether a particular condition is true. The indicator usually takes the form of a single binary digit, or bit (either 0 or 1). (from Dictionary of Computers)","longName":"2437803v1.0:2437768v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2437803","version":"1","preferredName":"Pharmacologic Substance","preferredDefinition":"A natural, synthetic or semi-synthetic substance including endogenous body substance used to diagnose, prevent, maintain, treat or analyze abnormal and normal biological functions in vivo or in vitro.","longName":"C1909","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pharmacologic Substance","conceptCode":"C1909","definition":"Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07F9D768-37A3-6CA7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-15","endDate":null,"createdBy":"UMLLOADER_CAMOD","dateCreated":"2005-12-15","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2437768","version":"1","preferredName":"Cancer Molecular Analysis Project Pharmacologic Substance Flag","preferredDefinition":"Through the Cancer Molecular Analysis Project (CMAP), NCI facilitates the identification and evaluation of molecular targets by integrating comprehensive molecular characterizations of cancer and making the data and infrastructure publicly accessible. CMAP permits investigators to 1) Discover molecular targets, 2) Assess their validity and interaction with other targets, 3) Determine if there are therapeutic agents that can act on specific targets, 4) Screen for possible toxicity, and 5) Determine whether there are clinical trials evaluating these agents. (http://plan2005.cancer.gov/bioinformatics.html):A natural, synthetic or semi-synthetic substance including endogenous body substance used to diagnose, prevent, maintain, treat or analyze abnormal and normal biological functions in vivo or in vitro.:An indicator that can be set or unset in order to signal whether a particular condition is true. The indicator usually takes the form of a single binary digit, or bit (either 0 or 1). (from Dictionary of Computers)","longName":"C48274:C1909:C43578","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cancer Molecular Analysis Project","conceptCode":"C48274","definition":"Through the Cancer Molecular Analysis Project (CMAP), NCI facilitates the identification and evaluation of molecular targets by integrating comprehensive molecular characterizations of cancer and making the data and infrastructure publicly accessible. CMAP permits investigators to 1) Discover molecular targets, 2) Assess their validity and interaction with other targets, 3) Determine if there are therapeutic agents that can act on specific targets, 4) Screen for possible toxicity, and 5) Determine whether there are clinical trials evaluating these agents.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Pharmacologic Substance","conceptCode":"C1909","definition":"Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Flag","conceptCode":"C43578","definition":"An indicator that can be set or unset in order to signal whether a particular condition is true.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07F9BE64-76B2-65C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-15","endDate":null,"createdBy":"UMLLOADER_CAMOD","dateCreated":"2005-12-15","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2222502","version":"1","preferredName":"UML DEFAULT CD","preferredDefinition":"Default Conceptual Domain for UML Loader","longName":"UML DEFAULT CD","context":"caCORE","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5E53F3B-47A4-52D1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-04-29","modifiedBy":"DWARZEL","dateModified":"2021-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"07FB2B12-284C-094C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-15","endDate":null,"createdBy":"UMLLOADER_CAMOD","dateCreated":"2005-12-15","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2178538","version":"1","preferredName":"java.lang.Boolean","preferredDefinition":"Generic value domain for a primitive java datatype that is a Boolean value (true or false).","longName":"java.lang.Boolean","context":"caCORE","contextVersion":"1","type":"Non-enumerated","dataType":"java.lang.Boolean","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2178532","version":"1","preferredName":"Bioinformatics","preferredDefinition":".","longName":"BIOINFORMATICS","context":"caCORE","contextVersion":"1","origin":null,"workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"CD81DD3C-8FFA-28BA-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-12-02","endDate":"2020-10-14","createdBy":"SBREXT","dateCreated":"2003-12-02","modifiedBy":"TAYLORT","dateModified":"2020-10-14","changeDescription":"10.14.20 TL changed WFS from DRAFT NEW to RETIRED ARCHIVED and added an End Date in preparation of OneData.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2320047","version":"1","preferredName":"Indicator","preferredDefinition":"An event, entity or condition that typically characterizes a prescribed environment or situation. Indicators determine or aid in determining whether or not certain stated circumstances exist or criteria are satisfied. (On-line Medical Dictionary)","longName":"C25180","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Indicator","conceptCode":"C25180","definition":"An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"FC6EF0D8-521A-6865-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-25","modifiedBy":"ONEDATA","dateModified":"2005-07-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CD831153-DAB5-28B6-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-12-02","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-02","modifiedBy":"CURTIST","dateModified":"2007-12-05","changeDescription":"03/30/2006 - Updated defintion and datatype (previously Boolean).","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2534690","version":"2.5","longName":"caMOD_2.5","context":"NCIP","ClassificationSchemeItems":[{"publicId":"10000547","version":"1","longName":"gov.nih.nci.camod.domain","context":"NCIP"}]},{"publicId":"2939183","version":"4.3","longName":"caBIO 4.3","context":"NCIP","ClassificationSchemeItems":[{"publicId":"10000544","version":"1","longName":"gov.nih.nci.cabio.domain","context":"NCIP"}]}],"AlternateNames":[{"name":"gov.nih.nci.camod.domain.Agent.isCMAPAgent","type":"UML Qualified Attr","context":"NCIP"},{"name":"Agent:isCMAPAgent","type":"UML Class:UML Attr","context":"NCIP"},{"name":"gov.nih.nci.cabio.domain.Agent.isCMAPAgent","type":"UML Qualified Attr","context":"NCIP"},{"name":"@isCMAPAgent","type":"GME_XMLLocReference","context":"NCIP"}],"ReferenceDocuments":[{"name":"Data Element Pharmacologic Substance Cancer Molecular Analysis Project Pharmacologic Substance Flag java.lang.Boolean does not have Preferred Question Text","type":"Preferred Question Text","description":"Data Element Pharmacologic Substance Cancer Molecular Analysis Project Pharmacologic Substance Flag java.lang.Boolean does not have Preferred Question Text","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"07FC005F-EF26-300A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-15","endDate":null,"createdBy":"UMLLOADER_CAMOD","dateCreated":"2005-12-15","modifiedBy":"UMLLDR","dateModified":"2009-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}